Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 991 AL 1005

The future of Alzheimer's disease: the next 10 years

Hampel H, Prvulovic D, Teipel S, Jessen F, Luckhaus C, Frölich L, Riepe MW, Dodel R, Leyhe T, Bertram L, Hoffmann W, Faltraco F; German Task Force on Alzheimer's Disease (GTF-AD).

Prog Neurobiol. 2011 Dec;95(4):718-28. doi: 10.1016/j.pneurobio.2011.11.008. Epub 2011 Nov 22.

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants

Mayeux R, Schupf N.

Neurobiol Aging. 2011 Dec;32 Suppl 1(Suppl 1):S10-9. doi: 10.1016/j.neurobiolaging.2011.09.004.

Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia

Klunk WE.

Neurobiol Aging. 2011 Dec;32 Suppl 1(Suppl 1):S20-36. doi: 10.1016/j.neurobiolaging.2011.09.006.

Potential of functional MRI as a biomarker in early Alzheimer's disease

Sperling R.

Neurobiol Aging. 2011 Dec;32 Suppl 1(Suppl 1):S37-43. doi: 10.1016/j.neurobiolaging.2011.09.009.

Alliance for aging research AD biomarkers work group: structural MRI

Jack CR Jr.

Neurobiol Aging. 2011 Dec;32 Suppl 1(0 1):S48-57. doi: 10.1016/j.neurobiolaging.2011.09.011.

Changes in cognition

Albert MS.

Neurobiol Aging. 2011 Dec;32 Suppl 1(0 1):S58-63. doi: 10.1016/j.neurobiolaging.2011.09.010.

Obesity, leptin, and Alzheimer's disease

Lee EB.

Ann N Y Acad Sci. 2011 Dec;1243:15-29. doi: 10.1111/j.1749-6632.2011.06274.x.

Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets

Lee VM, Brunden KR, Hutton M, Trojanowski JQ.

Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006437. doi: 10.1101/cshperspect.a006437.

C-peptide and its correlation to parameters of insulin resistance in the metabolic syndrome

Banu S, Jabir NR, Manjunath CN, Shakil S, Kamal MA.

CNS Neurol Disord Drug Targets. 2011 Dec;10(8):921-7. doi: 10.2174/187152711799219271.

The cerebrovascular role of the cholinergic neural system in Alzheimer's disease

Van Beek AH, Claassen JA.

Behav Brain Res. 2011 Aug 10;221(2):537-42. doi: 10.1016/j.bbr.2009.12.047. Epub 2010 Jan 7.

Cell cycle regulation distinguishes lymphocytes from sporadic and familial Alzheimer's disease patients

Bialopiotrowicz E, Kuzniewska B, Kachamakova-Trojanowska N, Barcikowska M, Kuznicki J, Wojda U.

Neurobiol Aging. 2011 Dec;32(12):2319.e13-26. doi: 10.1016/j.neurobiolaging.2010.04.017. Epub 2010 Jun 11.

Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database

Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehéricy S, Habert MO, Chupin M, Benali H, Colliot O; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 May 15;56(2):766-81. doi: 10.1016/j.neuroimage.2010.06.013. Epub 2010 Jun 11.

The role of tau in Alzheimer's disease and related disorders

Medeiros R, Baglietto-Vargas D, LaFerla FM.

CNS Neurosci Ther. 2011 Oct;17(5):514-24. doi: 10.1111/j.1755-5949.2010.00177.x. Epub 2010 Jun 14.

The link between iron, metabolic syndrome, and Alzheimer's disease

Grünblatt E, Bartl J, Riederer P.

J Neural Transm (Vienna). 2011 Mar;118(3):371-9. doi: 10.1007/s00702-010-0426-3. Epub 2010 Jun 17.

Heme oxygenase-1 in Alzheimer disease: a tribute to Moussa Youdim

Schipper HM.

J Neural Transm (Vienna). 2011 Mar;118(3):381-7. doi: 10.1007/s00702-010-0436-1. Epub 2010 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias